Thomas Ludwig

4.6k total citations · 2 hit papers
45 papers, 3.5k citations indexed

About

Thomas Ludwig is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Thomas Ludwig has authored 45 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 21 papers in Oncology and 11 papers in Genetics. Recurrent topics in Thomas Ludwig's work include DNA Repair Mechanisms (23 papers), CRISPR and Genetic Engineering (11 papers) and BRCA gene mutations in cancer (9 papers). Thomas Ludwig is often cited by papers focused on DNA Repair Mechanisms (23 papers), CRISPR and Genetic Engineering (11 papers) and BRCA gene mutations in cancer (9 papers). Thomas Ludwig collaborates with scholars based in United States, China and Spain. Thomas Ludwig's co-authors include Richard Baer, Yingming Zhao, Minjia Tan, Ning Kon, Wei Gu, Le Jiang, Tongyuan Li, Reena Shakya, Maria Jasin and Matthias Szabolcs and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas Ludwig

45 papers receiving 3.5k citations

Hit Papers

Tumor Suppression in the Absence of p53-Mediated Cell-Cyc... 2012 2026 2016 2021 2012 2016 200 400 600

Peers

Thomas Ludwig
Tiffany N. Seagroves United States
Dimitris Athineos United Kingdom
Sergei Kozlov Australia
Frances Kittrell United States
Cyrus Vaziri United States
Elena A. Komarova United States
Thomas Ludwig
Citations per year, relative to Thomas Ludwig Thomas Ludwig (= 1×) peers Denis Biard

Countries citing papers authored by Thomas Ludwig

Since Specialization
Citations

This map shows the geographic impact of Thomas Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ludwig more than expected).

Fields of papers citing papers by Thomas Ludwig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ludwig. The network helps show where Thomas Ludwig may publish in the future.

Co-authorship network of co-authors of Thomas Ludwig

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ludwig. A scholar is included among the top collaborators of Thomas Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ludwig. Thomas Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Dongju, Reena Shakya, Christopher S. Koivisto, et al.. (2019). Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains. PLoS ONE. 14(12). e0226714–e0226714. 7 indexed citations
2.
Chiang, Huai-Chin, Xiaowen Zhang, Sabrina Smith, et al.. (2018). Gene-Specific Genetic Complementation between Brca1 and Cobra1 During Mouse Mammary Gland Development. Scientific Reports. 8(1). 2731–2731. 3 indexed citations
3.
Cole, Francesca, Joonyoung Her, Amy J. Malhowski, et al.. (2016). 53 BP 1 ablation rescues genomic instability in mice expressing ‘ RING ‐less’ BRCA 1. EMBO Reports. 17(11). 1532–1541. 35 indexed citations
4.
Mace, Thomas A., Reena Shakya, Jason R. Pitarresi, et al.. (2016). IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. Gut. 67(2). 320–332. 401 indexed citations breakdown →
5.
Manuel, Edwin R., Massimo D’Apuzzo, Teodora Kaltcheva, et al.. (2015). Salmonella -Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors. Cancer Immunology Research. 3(9). 1096–1107. 53 indexed citations
6.
Chatterjee, Moumita, Edgar Ben‐Josef, Dafydd G. Thomas, et al.. (2015). Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer. Scientific Reports. 5(1). 10867–10867. 85 indexed citations
7.
Duann, Pu, Haichang Li, Pei‐Hui Lin, et al.. (2015). MG53-mediated cell membrane repair protects against acute kidney injury. Science Translational Medicine. 7(279). 279ra36–279ra36. 109 indexed citations
8.
Sonabend, Adam M., Mukesh Bansal, Paolo Guarnieri, et al.. (2014). The Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor Progression. Cancer Research. 74(5). 1440–1451. 41 indexed citations
9.
Gupta, Arun, Clayton R. Hunt, Muralidhar L. Hegde, et al.. (2014). MOF Phosphorylation by ATM Regulates 53BP1-Mediated Double-Strand Break Repair Pathway Choice. Cell Reports. 8(1). 177–189. 73 indexed citations
10.
Simhadri, Srilatha, Shaun Peterson, Yanying Huo, et al.. (2014). Male Fertility Defect Associated with Disrupted BRCA1-PALB2 Interaction in Mice. Journal of Biological Chemistry. 289(35). 24617–24629. 57 indexed citations
11.
Shakya, Reena, Tamas A. Gonda, Michael Quante, et al.. (2012). Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma. Cancer Research. 73(2). 885–896. 62 indexed citations
12.
Salas, Martha, Hong Zhang, Julia Gittler, et al.. (2012). Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1). Mammalian Genome. 24(1-2). 30–43. 11 indexed citations
13.
Bunting, Samuel F., Elsa Callén, Marina Kozak, et al.. (2012). BRCA1 Functions Independently of Homologous Recombination in DNA Interstrand Crosslink Repair. Molecular Cell. 46(2). 125–135. 200 indexed citations
14.
Héroult, Mélanie, Florence Schaffner, Dennis Pfaff, et al.. (2010). EphB4 Promotes Site-Specific Metastatic Tumor Cell Dissemination by Interacting with Endothelial Cell–Expressed EphrinB2. Molecular Cancer Research. 8(10). 1297–1309. 36 indexed citations
15.
Zhou, Guangming, Lubomir B. Smilenov, Howard B. Lieberman, Thomas Ludwig, & Eric J. Hall. (2010). Radiosensitivity to high energy iron ions is influenced by heterozygosity for Atm, Rad9 and Brca1. Advances in Space Research. 46(6). 681–686. 1 indexed citations
16.
Su, Fengtao, Lubomir B. Smilenov, Thomas Ludwig, et al.. (2010). Hemizygosity for Atm and Brca1 influence the balance between cell transformation and apoptosis. Radiation Oncology. 5(1). 15–15. 14 indexed citations
17.
Tao, Xiang, Amiko Ohashi, Yuping Huang, et al.. (2008). Negative Regulation of AKT Activation by BRCA1. Cancer Research. 68(24). 10040–10044. 113 indexed citations
18.
Choudhury, Atish D., et al.. (2005). Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells. Journal of Biological Chemistry. 280(26). 24669–24679. 10 indexed citations
19.
Lowry, Philip W., Thomas Ludwig, Julie A. Adams, et al.. (1998). Cellular Immune Responses to Four Doses of Percutaneous Bacille Calmette-Guerin in Healthy Adults. The Journal of Infectious Diseases. 178(1). 138–146. 21 indexed citations
20.
Metzger, Rainer, Michael Bäder, Thomas Ludwig, et al.. (1995). Expression of the mouse and rat mas proto‐oncogene in the brain and peripheral tissues. FEBS Letters. 357(1). 27–32. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026